Cyber Resilience

CVE-2023-40153

Medium

Published: 19 October 2023

Published
19 October 2023
Modified
21 November 2024
KEV Added
Patch
CVSS Score v3.1 5.4 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
EPSS Score 0.0026 49.6th percentile
Risk Priority 11 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2023-40153 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Dexma Dexgate. Its CVSS base score is 5.4 (Medium).

Operationally, ranked at the 49.6th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.

CWE(s)

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

dexma
dexgate
20130114

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

addresses: CWE-79

Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.

addresses: CWE-79

Validates web inputs to reject script-related content that could produce XSS.

addresses: CWE-79

Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.

References